| Q34005026 | A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions |
| Q33260497 | Alternative technologies in cervical cancer screening: a randomised evaluation trial |
| Q36625937 | An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme |
| Q45382469 | Barriers to acceptance of self-sampling for human papillomavirus across ethnolinguistic groups of women. |
| Q35153329 | Cancer screening in renal transplant recipients: what is the evidence? |
| Q36314565 | Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media |
| Q50959392 | Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial. |
| Q33182247 | Diagnosis of human papillomavirus infection by dry vaginal swabs in military women |
| Q34051722 | Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial. |
| Q34251068 | Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study |
| Q33806772 | European consensus on cancer screening should be applied urgently by health ministers |
| Q36511847 | Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall |
| Q36671682 | Extended duration of the detectable stage by adding HPV test in cervical cancer screening |
| Q36645984 | Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle |
| Q42140279 | Gynecologic issues in the HIV-infected woman |
| Q34511387 | HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico |
| Q35073297 | Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. |
| Q34679465 | Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study |
| Q43201169 | Human papillomavirus testing in cervical cancer screening |
| Q24198236 | Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions |
| Q33806254 | Human papillomavirus testing. Authors' comments |
| Q37296790 | Long-term follow-up of HPV16-positive women: persistence of the same genetic variant and low prevalence of variant co-infections |
| Q35398350 | Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference |
| Q37873036 | Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs. |
| Q45812304 | Proceedings From the First Asia-Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) Meeting |
| Q34363171 | Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study |
| Q43011550 | Self testing for human papillomaviruses. |
| Q36616533 | The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up |
| Q33918743 | What we could do now: molecular pathology of gynaecological cancer |
| Q52066278 | Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts? |